有机化学人才网 | 最新人才 | 最新职位 | 有机化学论坛 | 技术交易 | 药物合成 | 企业大全 | CAS大全 注册 | 登陆
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Metronidazole;IDR-90105(Ophthalmic);Rosased;Zidoval;Metrogel;Flagyl
Chemical Name 2-Methyl-5-nitro-1H-imidazole-1-ethanol
CAS 443-48-1
Related CAS 133884-00-1 (deleted CAS)
Formula C6H9N3O3
Structure
Formula Weight 171.15693
Stage 上市-1960
Company Pfizer (Originator), 3M Pharmaceuticals (Not Determined), Novartis (Not Determined), Pierre Fabre (Not Determined), Institute for Drug Research (Licensee)
Activity/Mechanism Acne Therapy, Antiamebics, Antibacterial Drugs, Antibacterial Ophthalmic Drugs, Antifungal Agents, ANTIINFECTIVE THERAPY, Antitrichomonals, DERMATOLOGIC DRUGS, Ocular Antiinflammatory and Antiinfective Agents, OCULAR MEDICATIONS, Ophthalmic Drugs, Treatment of Protozoal Diseases
Syn. Route 6
Route 1
2-methylimidazole (i) is converted into the bisulfate salt, and then nitrated by means of a sulfonitric mixture in ac2o to produce 2-methyl-4-nitroimidazole (ii) . in a variant of this procedure, 2-methylimidazole (i) is nitrated by using a ferric nitrate-tonsyl adduct in several solvents. imidazole (ii) is then regioselectively alkylated with boiling 2-chloroethanol to produce the title compound. alternatively, the alkylation of (ii) has been reported by treatment with ethylene oxide (iii) under acidic conditions.
List of intermediates No.
3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-4-phenyl-1,4-dihydropyridine (iii)
(3ar,6as)-2-oxohexahydro-2h-cyclopenta[b]furan-4-carbaldehyde (i)
ethyl (1r,2s,4r)-2-isopropenyl-1-methyl-4-vinylcyclohexanecarboxylate (ii)
Reference 1:
    frank, a.; karn, h.; spanig, h. (abbott gmbh & co. kg); production of 1-hydroxyalkyl-5-nitroimidazoles. de 2359625; fr 2253019; gb 1481349 .
Reference 2:
    frank, a.; dockner, t.; karn, h. (abbott gmbh & co. kg); process for the preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole of high purity. ep 0150407 .

Route 2
in an alternative procedure, the title compound is obtained by hydrolysis of the bromoethyl imidazole (i) in the presence of formic acid in aqueous formamide
List of intermediates No.
Reference 1:
    sunjic, v.; fajdiga, t.; kajfez, f.; process for preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole. de 1695321; gb 1138805; us 3520900 .

Route 3
the title compound can be obtained by reaction of 1-(acetoxymethyl)-2-methyl-4-nitroimidazole (i) with ethylene oxide (ii) in the presence of sulfur trioxide, followed by hydrolysis in aqueous h2so4
List of intermediates No.
3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-4-phenyl-1,4-dihydropyridine (ii)
Reference 1:
    lavigne, m.; mandard-cazin, b. (aventis pharma sa); process for preparing hydroxyalkyl-1 nitro-5 imidazoles. wo 9113877 .

Route 4
in a related procedure, 1-(acetoxymethyl)-2-methyl-4-nitroimidazole (i) is condensed with ethyleneglycol diacetate (ii) in the presence of anhydrous h2so4, followed by hydrolysis or alcoholysis under acidic conditions to produce the title compound
List of intermediates No.
Reference 1:
    buforn, a.; massonneau, v.; mulhauser, m. (aventis sa); process for the preparation of 1-hydroxyalkyl-2-methyl-5-nitro-imidazoles. ep 0325513; fr 2625999 .

Route 5
alternatively, 2-methyl-4-nitroimidazole (i) is protected by acylation in hot acetic anhydride to give (ii). addition of ethylene oxide (iii) to the n-acetyl imidazole (ii) in the presence of so3, followed by acidic hydrolysis furnishes the title compound
List of intermediates No.
3-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-4-phenyl-1,4-dihydropyridine (iii)
ethyl (1r,2s,4r)-2-isopropenyl-1-methyl-4-vinylcyclohexanecarboxylate (i)
Reference 1:
    lavigne, m.; mandard-cazin, b. (aventis pharma sa); process for preparing hydroxyalkyl-1 nitro-5 imidazoles. wo 9113877 .

Route 6
the title compound can also be obtained by alkylation, in different solvents, of 1-(acetoxymethyl)-2-methyl-4-nitroimidazole (i) with either ethylene sulfate (ii) or with bis-(2-acetoxyethyl) sulfate (iii) -generated from ethyleneglycol diacetate (iv) and either dimethyl sulfate or h2so4 - followed by hydrolysis or alcoholysis treatment
List of intermediates No.
Reference 1:
    massonneau, v.; mulhauser, m.; buforn, a. (aventis pharma sa); process for the preparation of hydroxyalkylating agents, the agents so prepared and their use. ep 0324692 .
Reference 2:
    massonneau, v.; mulhauser, m.; buforn, a.; madard-cazin, b. (aventis pharma sa); process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles. ep 0324691 .

 
推荐VIP企业
宁波赛伦化工有限公司
无锡景耀生物科技有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
北京梅尔森医药技术开发有限公
热门文章
华东粗苯市场高位坚挺
宁波二甘醇市场震荡整理
华东二甘醇市场震荡
山西粗苯市场高位坚挺
华北市场苯乙烯市场淡稳观望
华东地区邻二甲苯价格平稳
华东港口丙烯腈市场报价暂稳
华北地区醋酐市场行情稳定
环氧乙烷市场高位运行为主
河北地区顺酐市场平稳
华中地区醋酐市场走势稳定
华南地区顺酐市场平稳
华南二甘醇市场窄幅整理
河北粗苯市场高位整理
山东地区顺酐市场价格暗降
宁波二甘醇市场小幅震荡
山西地区顺酐市场无价无市
华中地区醋酐市场走势稳定
华东地区醋酐市场行情稳定
华东地区邻二甲苯价格平稳
 友情链接
有机化学人才网  有机化学论坛
首页 | 会员级别 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明